Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Reed

Showing results (221-230 of 263) with videos related to

Pageof 27
Sort By:
Virology|December 3, 2014
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaquesMichael A Thomas, Iskra Tuero, Thorsten Demberg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2023
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammationTaishi Kimura, Joseph M Leal, Adrian Simpson, et al.
Frontiers in Immunology|October 9, 2024
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humansAndrew Fiore-Gartland, Himangi Srivastava, Aaron Seese, et al.
Vaccine|May 5, 2016
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral LeishmaniasisMalcolm S Duthie, Michelle Favila, Kimberley A Hofmeyer, et al.
Frontiers in Microbiology|February 11, 2025
Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of <i>Leishmania major</i> in cutaneous leishmaniasis patientsInsaf Bel Hadj Ali, Yusr Saadi-Ben Aoun, Imen Khammeri, et al.
Frontiers in Immunology|January 12, 2019
<i>Mycobacterium leprae</i> Recombinant Antigen Induces High Expression of Multifunction T Lymphocytes and Is Promising as a Specific Vaccine for LeprosyMárcio Bezerra-Santos, Marise do Vale-Simon, Aline Silva Barreto, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Scientific Reports|December 14, 2016
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine AdjuvantsThorunn A Olafsdottir, Madelene Lindqvist, Intawat Nookaew, et al.
Molecular Therapy. Methods & Clinical Development|July 23, 2020
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus InfectionJesse H Erasmus, Jacob Archer, Jasmine Fuerte-Stone, et al.
Plos Neglected Tropical Diseases|January 29, 2019
Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosumFrancianne M Amorim, Maurício L Nobre, Larissa S Nascimento, et al.
Pageof 27

Showing results (221-230 of 263) with videos related to

Sort By:
Pageof 27
Virology|December 3, 2014
HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaquesMichael A Thomas, Iskra Tuero, Thorsten Demberg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2023
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammationTaishi Kimura, Joseph M Leal, Adrian Simpson, et al.
Frontiers in Immunology|October 9, 2024
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humansAndrew Fiore-Gartland, Himangi Srivastava, Aaron Seese, et al.
Vaccine|May 5, 2016
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral LeishmaniasisMalcolm S Duthie, Michelle Favila, Kimberley A Hofmeyer, et al.
Frontiers in Microbiology|February 11, 2025
Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of <i>Leishmania major</i> in cutaneous leishmaniasis patientsInsaf Bel Hadj Ali, Yusr Saadi-Ben Aoun, Imen Khammeri, et al.
Frontiers in Immunology|January 12, 2019
<i>Mycobacterium leprae</i> Recombinant Antigen Induces High Expression of Multifunction T Lymphocytes and Is Promising as a Specific Vaccine for LeprosyMárcio Bezerra-Santos, Marise do Vale-Simon, Aline Silva Barreto, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Scientific Reports|December 14, 2016
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine AdjuvantsThorunn A Olafsdottir, Madelene Lindqvist, Intawat Nookaew, et al.
Molecular Therapy. Methods & Clinical Development|July 23, 2020
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus InfectionJesse H Erasmus, Jacob Archer, Jasmine Fuerte-Stone, et al.
Plos Neglected Tropical Diseases|January 29, 2019
Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosumFrancianne M Amorim, Maurício L Nobre, Larissa S Nascimento, et al.
Pageof 27